Characterization of the Anti-Alzheimer Drug Lecanemab by Mass Spectrometry.

Sha J, Geng Z, Qi S, Du L, Hu Q, Cai M, Chen D, Chen Y, Liu S, Song H, Ling T, Chang C, Bai B

Open source

DOI
10.1021/acsomega.6c02666
Published
2026 Jun 23
Container
ACS omega
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsomega.6c02666,
  title = {Characterization of the Anti-Alzheimer Drug Lecanemab by Mass Spectrometry.},
  author = {Sha J and Geng Z and Qi S and Du L and Hu Q and Cai M and Chen D and Chen Y and Liu S and Song H and Ling T and Chang C and Bai B},
  year = {2026},
  journal = {ACS omega},
  doi = {10.1021/acsomega.6c02666},
  url = {https://doi.org/10.1021/acsomega.6c02666}
}

RIS

TY  - JOUR
TI  - Characterization of the Anti-Alzheimer Drug Lecanemab by Mass Spectrometry.
AU  - Sha J
AU  - Geng Z
AU  - Qi S
AU  - Du L
AU  - Hu Q
AU  - Cai M
AU  - Chen D
AU  - Chen Y
AU  - Liu S
AU  - Song H
AU  - Ling T
AU  - Chang C
AU  - Bai B
PY  - 2026
JO  - ACS omega
DO  - 10.1021/acsomega.6c02666
UR  - https://doi.org/10.1021/acsomega.6c02666
ER  - 

APA

J, S., Z, G., S, Q., L, D., Q, H., M, C., D, C., Y, C., S, L., H, S., T, L., C, C., & B, B. (2026). Characterization of the Anti-Alzheimer Drug Lecanemab by Mass Spectrometry.. ACS omega. https://doi.org/10.1021/acsomega.6c02666

Source records